finanzen.pr-ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen.Presse Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
30.07.2008 22:40:08
Eli Lilly and Company: Chicago (ots/PRNewswire) - - Findings lead to decision to start Phase III pivotal study of LY2062430 in 2009 Eli Lilly and Company (NYSE: LLY) today announced interim results of its Phase II study of LY2062430, an ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
- Beta Systems und Proginet stärken Kernkompetenzen durch Technologietransfer
- Beta Systems delivers a convincing performance with sales successes and an increase in profit in the first half of 2008
- Beta Systems and Proginet Strengthen Core Competencies with Strategic Technology Exchange
- euro adhoc: Beta Systems Software AG / Board of Directors (Appointments and Changes) / Beta Systems extends contract with CFO Gernot Sagl for three years
- euro adhoc: Beta Systems Software AG / Vorstand/Personalie / Beta Systems verlängert Vertrag mit Finanzvorstand Gernot Sagl um drei Jahre
- Movetis Presents New Data at Digestive Disease Week
- Beta Systemsüberzeugt mit Vertriebserfolgen und Ergebnisplus im ersten Halbjahr 2008
- NTT Data erwirbt 72,9 Prozent an Cirquent von BMW
- Beta Systems again raises revenues and the result at the end of the first nine months of 2008
Presseportal: Eli Lilly and Company - Lilly Oncology plant starken ...
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Pressemitteilungen und Pressemeldungen vom 30.07.2008 | PresseEcho.de
News.Taeglich aktuelle Meldungen aus Bereichen wie Finanzen, Wirtschaft, Computer & IT, Sport Phase II Data on Lilly's Antibody Show It Affects Amyloid
Presseportal: Meldung versenden
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with E-Mail-Adresse des Empfängers: Sie können max.5
Presseportal.de - Eli Lilly and Company
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated Phase III Trial for Treatment of Alzheimer's Disease